Clinical Trials Management System (CTMS) “OnCore”

Jan 4, 2021 | Conduits News

ConduITS the Clinical & Translational Science Award at Mount Sinai received an administrative supplement from NCATS the NIH center that funds the CTSA program in August of 2018 to implement a system-wide Clinical Trials Management System (CTMS) “OnCore”. The Office of Research Services (ORS) within ConduITs is implementing the CTMS. OnCore will standardize clinical research (C/R) oversight in research compliance, billing and the conduct of C/R trials, allow institution-wide reporting of C/R metrics, and centralize access to the ISMMS research portfolio improving the management of Clinical Trials conducted at the Mount Sinai Health System.

In March of 2020, the enterprise roll-out of OnCore CTMS was put on hold due to the COVID-19 pandemic as most study personnel were deployed to assist with the pandemic as non-essential research was put on hold. ORS pivoted the focus of the system-wide implementation toward the use of OnCore to manage COIVD-19 clinical trials. This allowed the ORS to enhance the management of the COVID-19 Protocol Review Committee and disseminate a list of active COVID-19 clinical trials to clinicians across the health system. The ORS is currently working with the Epic team to develop a report of patients enrolled in COVID-19 to reduce redundancies in matching eligible patients to active studies.

The ORS also used the time to develop enhanced and remote e-learning and training resources for OnCore. With the help of Levy Library, the OnCore CTMS End-User Training eLearning Modules were created using the software Camtasia and were tailored to the Mount Sinai research community. As we adjusted to the “new normal”, these eLearning modules expedited the process of training new users. This allowed study teams adjusting to different schedules and working remotely to have access to the training resources at any time.

In late August when the enterprise roll-out resumed, the eLearning Modules became a pre-requisite for teams to complete prior to Go-Live Training conducted via Zoom. Prior to the development of the eLearning modules, Go-Live Training would typically take an entire work day, but has now has turned into a 2 ½ hour live training session. In addition to the resumption of the enterprise roll-out of OnCore CTMS, ORS has begun the process of collaborating with the Tisch Cancer Institute by assisting with the Clinical Research Coordinator Training in OnCore CTMS.

Anticipated date of completion of the enterprise roll-out is May 2021.

The OnCore CTMS End-User Training eLearning Modules are expected to be available in PEAK by December of 2021.

If you have any questions or want to read about updates to the OnCore role out contact Research411 or go to The Research Roadmap.

ConduITS is supported by NCATS of the NIH’s CTSA Program. Any use of CTSA-supported resources requires citation of grant number UL1TR001433 awarded to ISMMS in the acknowledgment section of every publication resulting from this support. Adherence to the NIH Public Access Policy is also required.

 

 

 

Recent ConduITS News

Newsletter Special Edition

Click here to view the special edition of the Conduit Newsletter, designed in CANVA! As part of a new initiative by The Mount Sinai ConduITS Institutes for Translational Sciences (CTSA), we are thrilled to introduce our latest newsletter designed to aid researchers in...

read more

Trainee Corner

Mount Sinai CTSA Featured Trainees

Megan Januska

Megan Januska

Megan Januska, MD is an Assistant Professor in the Division of Pediatric Pulmonology in the Jack and Lucy Clark Department of Pediatrics and in the Department of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai and Mount Sinai Kravis...

read more
Sangeetha Vadakke-Madathil

Sangeetha Vadakke-Madathil

Sangeetha Vadakke-Madathil, PhD, is currently a junior faculty (Instructor of Medicine) at Icahn School of Medicine at Mount Sinai, New York, NY. After receiving her Ph.D. degree in human hematopoietic stem cells and transplant biology from National Centre for Cell...

read more